Olink® Proteomics uses innovative Proximity Extension Assay (PEA) technology to deliver exceptional specificity and sensitivity across mid- and high-plex protein panels.
As a UK-based service provider of the Olink Proteomics portfolio, Source Genomics supports scalable proteomics studies spanning discovery, validation, and clinical research.
Quantify up to 5,400+ proteins with proven assay performance to gain deeper insights into disease biology at the protein level.
Contact us and one of our experienced account managers will arrange a complimentary consultation, including detailed information, workflow guidance, and transparent pricing options.
What Is Olink Proteomics?
Olink Proteomics is an antibody-based protein analysis platform that leverages Proximity Extension Assay (PEA) technology to measure relative and absolute protein abundance in liquid biopsies such as plasma and serum.
Each protein binding event is converted into a unique DNA barcode, enabling highly specific detection while minimising background noise. Readout is performed using NGS or qPCR, supporting both high-plex discovery and mid-plex targeted workflows.
Quantitative and Qualitative Protein Analysis
Olink® Explore (NGS Readout)
High-throughput profiling for large-scale biomarker discovery studies. Measure hundreds to thousands of proteins simultaneously with minimal sample input, ideal for population-scale and systems biology research.
Olink® Target 48 / 96 (qPCR Readout)
Pathway-focused panels designed for hypothesis-driven research and biomarker validation. Exceptional dynamic range enables detection of both low- and high-abundance proteins.
Olink® Flex
Customisable protein panels supporting targeted assay development and translational research.
Together, the Olink portfolio enables a seamless transition from discovery to validation and clinical utility.
Why Choose Olink for Proteomics?
Unlike traditional mass spectrometry approaches, Olink Proteomics delivers robust protein quantification without extensive sample preparation or complex workflows.
Capabilities and Performance
We employ advanced Proximity Extension Assay (PEA) technology to ensure accurate protein identification and quantification without the limitations of traditional mass spectrometry.
Olink® Explore and Reveal
High-throughput profiling of up to 5,400+ proteins using Next-Generation Sequencing (NGS) readout, ideal for large-scale biomarker discovery.
Olink® Target & Flex
Customisable and targeted panels for focused validation studies, utilising qPCR absolute and relative quantification.
These technologies enable high-sensitivity detection across broad dynamic ranges, allowing for the measurement of low-abundance biomarkers even in complex clinical matrices like plasma and serum.
Partial Plates Available
Don’t have enough samples for a full Explore 3k (88 samples)/Explore HT (172 samples) run? No problem. With Source Genomics, we can now offer full and partial plate solutions.*
*Subject to compatibility of sample matrix with other projects with recommended sample number of 43 samples for partial plate projects.
Supporting Clinical and Translational Proteomics
Olink Proteomics is ideal for scientists working in:
- Drug discovery and development
- Clinical research
- Translational and basic life sciences
Source Genomics supports proteomics research across a range of therapeutic areas, including:
- Cardiometabolic disease
- Oncology
- Neurology
- Inflammation and immune-mediated disorders
- Neurodegeneration
These applications enable biomarker discovery for disease prediction, drug target identification, patient stratification, and treatment response monitoring.
Accelerate your proteomics research with Olink® Proteomics. Contact us today to our team to discuss panel selection, study design, and sample requirements.